Upsher-Smith Laboratories LLC, a United States-based pharmaceutical company, has introduced its Ramelteon Tablets, 8mg, it was reported on Tuesday.

Upsher-Smith's product is AB-rated to the branded product, ROZEREM (ramelteon) tablets. The product is intended for the treatment of insomnia characterised by difficulty with sleep onset.

Rusty Field, president and CEO, Upsher-Smith, said, 'Expanding Upsher-Smith's portfolio of generic drug products and providing patients access to affordable generic medicines continues to be a priority. The launch of Ramelteon, the company's sixth generic product launch this year, clearly demonstrates the incredible resolve of our team in helping achieve these milestones during an unprecedented time.'